Cargando…

Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network

PURPOSE: Timely diagnosis of diabetic retinopathy (DR) can significantly improve the prognosis of patients. In this study, we established a prediction model by analyzing the relationship between diabetic retinopathy and related metabolic and biochemical indicators. METHODS: A total of 427 type 2 dia...

Descripción completa

Detalles Bibliográficos
Autor principal: Su, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450288/
https://www.ncbi.nlm.nih.gov/pubmed/34552342
http://dx.doi.org/10.2147/DMSO.S322224
_version_ 1784569608266579968
author Su, Bo
author_facet Su, Bo
author_sort Su, Bo
collection PubMed
description PURPOSE: Timely diagnosis of diabetic retinopathy (DR) can significantly improve the prognosis of patients. In this study, we established a prediction model by analyzing the relationship between diabetic retinopathy and related metabolic and biochemical indicators. METHODS: A total of 427 type 2 diabetes mellitus (T2DM) patients were selected from the datadryad website data. Logistic regression (MLR) was used to input layer variables of the model were screened. Then, Tan-Sigmoid was selected as the transfer function of the hidden layer node, and the linear function was used as the output layer function to establish the back propagation artificial neural network (BP-ANN) model. The model was applied to 183 patients with type 2 diabetes mellitus (T2DM) in our hospital to predict DR. RESULTS: A total of 167 patients (39.2%) with DR were obtained from the Datadryad database. Input variables were screened by MLR model, and it was concluded that the age, sex, albumin and creatinine, diabetes course were independently associated with the occurrence of DR. The above variables were used to establish BP-ANN model. The area under receiver operating characteristic curve (AUC) was significantly higher than that of MLR model (0.88 vs 0.74, P<0.05), the probability threshold of the model was 0.3. Type 2 diabetes mellitus (T2DM) were selected in our hospital, including 92 patients with DR (50.2%). The above BP-ANN model was used to predict the incidence of DR, and the AUC area was significantly higher than that of the MLR model (0.77 vs 0.70, P<0.05), the probability threshold was 0.7. CONCLUSION: We established the BP-ANN model and applied it to diagnose DR. Taking diabetic course, age, sex, albumin and creatinine as the inputs of BP-ANN, the existence of DR could be well predicted. Meanwhile, the generalization ability of the model could be improved by selecting different probability thresholds in different ROC curves.
format Online
Article
Text
id pubmed-8450288
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84502882021-09-21 Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network Su, Bo Diabetes Metab Syndr Obes Original Research PURPOSE: Timely diagnosis of diabetic retinopathy (DR) can significantly improve the prognosis of patients. In this study, we established a prediction model by analyzing the relationship between diabetic retinopathy and related metabolic and biochemical indicators. METHODS: A total of 427 type 2 diabetes mellitus (T2DM) patients were selected from the datadryad website data. Logistic regression (MLR) was used to input layer variables of the model were screened. Then, Tan-Sigmoid was selected as the transfer function of the hidden layer node, and the linear function was used as the output layer function to establish the back propagation artificial neural network (BP-ANN) model. The model was applied to 183 patients with type 2 diabetes mellitus (T2DM) in our hospital to predict DR. RESULTS: A total of 167 patients (39.2%) with DR were obtained from the Datadryad database. Input variables were screened by MLR model, and it was concluded that the age, sex, albumin and creatinine, diabetes course were independently associated with the occurrence of DR. The above variables were used to establish BP-ANN model. The area under receiver operating characteristic curve (AUC) was significantly higher than that of MLR model (0.88 vs 0.74, P<0.05), the probability threshold of the model was 0.3. Type 2 diabetes mellitus (T2DM) were selected in our hospital, including 92 patients with DR (50.2%). The above BP-ANN model was used to predict the incidence of DR, and the AUC area was significantly higher than that of the MLR model (0.77 vs 0.70, P<0.05), the probability threshold was 0.7. CONCLUSION: We established the BP-ANN model and applied it to diagnose DR. Taking diabetic course, age, sex, albumin and creatinine as the inputs of BP-ANN, the existence of DR could be well predicted. Meanwhile, the generalization ability of the model could be improved by selecting different probability thresholds in different ROC curves. Dove 2021-09-15 /pmc/articles/PMC8450288/ /pubmed/34552342 http://dx.doi.org/10.2147/DMSO.S322224 Text en © 2021 Su. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Su, Bo
Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network
title Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network
title_full Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network
title_fullStr Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network
title_full_unstemmed Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network
title_short Using Metabolic and Biochemical Indicators to Predict Diabetic Retinopathy by Back-Propagation Artificial Neural Network
title_sort using metabolic and biochemical indicators to predict diabetic retinopathy by back-propagation artificial neural network
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450288/
https://www.ncbi.nlm.nih.gov/pubmed/34552342
http://dx.doi.org/10.2147/DMSO.S322224
work_keys_str_mv AT subo usingmetabolicandbiochemicalindicatorstopredictdiabeticretinopathybybackpropagationartificialneuralnetwork